Annual Accounts Payable
$105.09 M
+$10.70 M+11.33%
December 31, 2024
Summary
- As of March 6, 2025, NVCR annual accounts payable is $105.09 million, with the most recent change of +$10.70 million (+11.33%) on December 31, 2024.
- During the last 3 years, NVCR annual accounts payable has risen by +$32.49 million (+44.75%).
- NVCR annual accounts payable is now at all-time high.
Performance
NVCR Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$105.09 M
+$13.77 M+15.08%
December 31, 2024
Summary
- As of March 6, 2025, NVCR quarterly accounts payable is $105.09 million, with the most recent change of +$13.77 million (+15.08%) on December 31, 2024.
- Over the past year, NVCR quarterly accounts payable has stayed the same.
- NVCR quarterly accounts payable is now at all-time high.
Performance
NVCR Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
NVCR Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +11.3% | 0.0% |
| 3 y3 years | +44.8% | +44.8% |
| 5 y5 years | +184.6% | +184.6% |
NVCR Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +44.8% | at high | +51.9% |
| 5 y | 5-year | at high | +184.6% | at high | +184.6% |
| alltime | all time | at high | +947.4% | at high | +947.4% |
NovoCure Limited Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $105.09 M(+11.3%) | $105.09 M(+15.1%) |
| Sep 2024 | - | $91.32 M(+1.3%) |
| Jun 2024 | - | $90.17 M(+6.9%) |
| Mar 2024 | - | $84.32 M(-10.7%) |
| Dec 2023 | $94.39 M(+10.8%) | $94.39 M(+18.5%) |
| Sep 2023 | - | $79.67 M(-3.5%) |
| Jun 2023 | - | $82.54 M(+1.3%) |
| Mar 2023 | - | $81.47 M(-4.4%) |
| Dec 2022 | $85.20 M(+17.4%) | $85.20 M(+10.6%) |
| Sep 2022 | - | $77.03 M(-3.6%) |
| Jun 2022 | - | $79.91 M(+15.5%) |
| Mar 2022 | - | $69.19 M(-4.7%) |
| Dec 2021 | $72.60 M(+35.3%) | $72.60 M(+21.0%) |
| Sep 2021 | - | $60.01 M(+5.7%) |
| Jun 2021 | - | $56.78 M(+7.7%) |
| Mar 2021 | - | $52.70 M(-1.8%) |
| Dec 2020 | $53.65 M(+45.3%) | $53.65 M(+27.1%) |
| Sep 2020 | - | $42.21 M(+9.6%) |
| Jun 2020 | - | $38.51 M(-4.7%) |
| Mar 2020 | - | $40.41 M(+9.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2019 | $36.92 M(+38.3%) | $36.92 M(+15.4%) |
| Sep 2019 | - | $32.00 M(+6.4%) |
| Jun 2019 | - | $30.07 M(+0.4%) |
| Mar 2019 | - | $29.94 M(+12.1%) |
| Dec 2018 | $26.71 M(+55.2%) | $26.71 M(+33.2%) |
| Sep 2018 | - | $20.05 M(-1.9%) |
| Jun 2018 | - | $20.43 M(+5.2%) |
| Mar 2018 | - | $19.42 M(+12.9%) |
| Dec 2017 | $17.21 M(-6.3%) | $17.21 M(+21.7%) |
| Sep 2017 | - | $14.14 M(+7.5%) |
| Jun 2017 | - | $13.16 M(-11.1%) |
| Mar 2017 | - | $14.80 M(-19.4%) |
| Dec 2016 | $18.36 M(+9.6%) | $18.36 M(+20.4%) |
| Sep 2016 | - | $15.24 M(-30.7%) |
| Jun 2016 | - | $22.01 M(+18.5%) |
| Mar 2016 | - | $18.58 M(+10.9%) |
| Dec 2015 | $16.75 M(+67.0%) | $16.75 M(+10.0%) |
| Sep 2015 | - | $15.23 M(+13.9%) |
| Jun 2015 | - | $13.38 M(+33.3%) |
| Dec 2014 | $10.03 M(-2.5%) | $10.03 M |
| Dec 2013 | $10.29 M | - |
FAQ
- What is NovoCure Limited annual accounts payable?
- What is the all time high annual accounts payable for NovoCure Limited?
- What is NovoCure Limited annual accounts payable year-on-year change?
- What is NovoCure Limited quarterly accounts payable?
- What is the all time high quarterly accounts payable for NovoCure Limited?
- What is NovoCure Limited quarterly accounts payable year-on-year change?
What is NovoCure Limited annual accounts payable?
The current annual accounts payable of NVCR is $105.09 M
What is the all time high annual accounts payable for NovoCure Limited?
NovoCure Limited all-time high annual accounts payable is $105.09 M
What is NovoCure Limited annual accounts payable year-on-year change?
Over the past year, NVCR annual accounts payable has changed by +$10.70 M (+11.33%)
What is NovoCure Limited quarterly accounts payable?
The current quarterly accounts payable of NVCR is $105.09 M
What is the all time high quarterly accounts payable for NovoCure Limited?
NovoCure Limited all-time high quarterly accounts payable is $105.09 M
What is NovoCure Limited quarterly accounts payable year-on-year change?
Over the past year, NVCR quarterly accounts payable has changed by $0.00 (0.00%)